Bansisons Tea Industries Ltd

📊 Novyra Pharmachem Q3 FY2026 Results: Net Loss of ₹1.15 Lakhs

• Net loss of ₹1.15 lakhs for Q3 ended Dec 31, 2025

• No revenue from operations in Q3

• Other income of ₹2.22 lakhs in Q3

• Nine-month net loss of ₹1.82 lakhs

• Nine-month other income of ₹6.31 lakhs

• Employee benefit expenses: ₹0.39 lakhs (Q3), ₹3.25 lakhs (9M)

• Finance costs: ₹0.73 lakhs (Q3), ₹2.18 lakhs (9M)

• EPS: Negative ₹0.02 (Q3), Negative ₹0.03 (9M)